Ever Fortune.AI Co., Ltd. (TPEX:6841)
66.70
+1.20 (1.83%)
Jan 23, 2026, 1:30 PM CST
Ever Fortune.AI Revenue
Ever Fortune.AI had revenue of 72.95M TWD in the quarter ending September 30, 2025, a decrease of -14.70%. This brings the company's revenue in the last twelve months to 342.37M, up 23.31% year-over-year. In the year 2024, Ever Fortune.AI had annual revenue of 337.52M with 259.13% growth.
Revenue (ttm)
342.37M
Revenue Growth
+23.31%
P/S Ratio
18.07
Revenue / Employee
n/a
Employees
74
Market Cap
6.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 337.52M | 243.54M | 259.13% |
| Dec 31, 2023 | 93.98M | 40.08M | 74.35% |
| Dec 31, 2022 | 53.90M | 15.66M | 40.94% |
| Dec 31, 2021 | 38.24M | 34.76M | 996.76% |
| Dec 31, 2020 | 3.49M | 2.29M | 190.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Hi-Clearance | 4.19B |
| Formosa Optical Technology | 3.98B |
| Pacific Hospital Supply | 2.47B |
| Savior Lifetec | 1.16B |
| Delta Asia International | 711.19M |
| Pharmosa Biopharm | 136.72M |